NCT03598998 2025-06-26Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell LymphomasCity of Hope Medical CenterPhase 1/2 Active not recruiting13 enrolled 12 charts
NCT00052442 2021-08-2510-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's LymphomaSpectrum Pharmaceuticals, IncPhase 1/2 Completed72 enrolled 12 charts